Bristol leadership search
This article was originally published in The Tan Sheet
Bristol-Meyers Squibb's search for a new CEO may be complicated by the widespread belief the company is an acquisition target. Bristol's board announced the termination of CEO Peter Dolan and General Counsel Richard Willard Sept. 12, following the failed settlement agreement with Apotex over Bristol's antithrombotic Plavix that prompted an investigation by the Department of Justice. James Cornelius, a former interim CEO of Guidant, was appointed interim CEO and VP by the board; he told the board he does not consider himself a candidate for the permanent position. Chairman James Robinson said during a Sept. 12 media call announcing Dolan's termination that the firm would "deal with any bona fide proposals that anybody wants to make," fueling acquisition speculation...
You may also be interested in...
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.
Japanese medical device manufacturer Terumo Corp. promoted senior management execs; MiMedx Group, developer of human placental tissue allografts, raised exec to CFO; and more.
COVID-19: String Of FDA Guidance Docs Lay Bare Enforcement Policies For Infusion Pumps, ECMO Devices, Thermometers, And More
In three separate immediately-in-effect guidance documents, the US agency says makers of infusion pumps and accessories, extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass devices, and remote ophthalmic assessment and monitoring devices can make “limited modifications” to those products so they can be used during the ongoing novel coronavirus crisis, without the need for firms to seek out a new 510(k). A fourth guidance says clinical electronic thermometers that aren’t yet 510(k)-cleared by the FDA can be distributed for use.